SLC6A3 and major depressive disorder: Notably, PEOs modulate key targets such as SLC6A4 (serotonin transporter) and SLC6A3 (dopamine transporter), regulating serotonergic and dopaminergic synaptic pathways and thereby alleviating menopause-associated depression [19].